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To the editor: We read with great interest the article by 
Orth et al. [1] in Eurosurveillance on a recent case of 
imported Plasmodium knowlesi infection in Germany. 
This case nicely illustrates the pivotal role of micros-
copy on thick and thin blood films by experienced 
microscopists for malaria diagnosis. The statement in 
the discussion section that only five cases imported to 
Europe have been published so far, underestimates the 
occurrence of this infection. Two more cases imported 
to the Netherlands have been described previously 
[2,3]. 
One case was a migrant worker from Malayan Borneo, 
positive in microscopy with 2% infected erythrocytes. 
The rapid BinaxNOW Malaria Test was positive for the 
pan-malarial aldolase band but negative for P. falci-
parum histidine-rich protein 2 (HRP-2). Retrospective 
analysis of the initial sample also showed positive 
results in the P. falciparum–specific lactate dehydroge-
nase (LDH) and pan-malarial LDH in the OptiMAL Rapid 
Malaria Test (DiaMed, Cressier, Switzerland). This 
patient was successfully treated with oral chloroquine 
for three days [2].
The other patient was a tourist who also visited 
Malayan Borneo and participated in a two-day jungle 
trek. At presentation, this case had a low parasitae-
mia (0.0005%) with microscopy and negative reactions 
for both HRP-2 and aldolase in the BinaxNOW Malaria 
Test. The patient was successfully treated with malar-
one, a combination of atovaquone and proguanil [3]. 
Both cases were confirmed as P. knowlesi infections by 
molecular methods after treatment had been started.
We agree with Orth et al that physicians should be 
aware of the possibility of imported P. knowlesi infec-
tions in travellers. This is particularly relevant, as 
P. knowlesi with its 24-hour replication cycle can result 
in a high parasitaemia and severe, life-threatening dis-
ease. It is safe to assume that the geographic range of 
P. knowlesi comprises all countries in south-east Asia, 
including the south of China.
Moreover, not only clinicians, but also laboratory per-
sonnel, traditionally only trained to identify the four 
more frequently observed Plasmodium species, P. fal-
ciparum, P. vivax, P. ovale and P. malariae, should be 
aware of this infection and its diagnostic challenges. 
P. knowlesi is morphologically very similar to P. 
malariae but can also be confused with P. falcipa-
rum in microscopy. As illustrated by the two cases 
described above, P. knowlesi infection causes variable 
results with commercially available rapid diagnostic 
tests, which do not seem to be reliable for diagnosis 
of P. knowlesi [3,4]. Although rapid diagnostic tests 
can complement microscopic diagnosis, they cannot 
replace microscopy, especially in patients with low par-
asite loads. For patients suspected of P. knowlesi infec-
tion, confirmation can be obtained either by specific 
PCR or by sequence analysis of generic Plasmodium 
PCR products, which are available in most specialised 
centres in Europe. While such confirmation is in pro-
gress, treatment should be installed based on positive 
blood smear results. From literature and our experi-
ence, it seems that oral treatment regimens suited for 
uncomplicated P. malariae and P. falciparum are also 
effective in clearing mild P. knowlesi infections, since 
resistance to antimalarial drugs has not been observed 
yet [5]. For more severe and complicated P. knowlesi 
infections, parenteral treatments associated with short 
parasite clearance times, such as artesunate, seem 
preferable.
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